Siponimod fumarate is the salt form of siponimod, a selective sphingosine-1-phosphate receptor modulator used as an active pharmaceutical ingredient. It is intended for once-daily oral administration in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1234627-85-0
Alpha/beta-Arteether
pharmaceutical raw material
Biperiden hydrochloride
pharmaceutical raw material
Azelnidipine
pharmaceutical raw material
Iguratimod
pharmaceutical raw material
(E)-but-2-enedioic acid;bis(1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidine-3-carboxylic acid)
JNLIKIBISICTMS-PEJBKAKVSA-N
CCC1=C(C=CC(=C1)/C(=N/OCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)/C)CN4CC(C4)C(=O)O.CCC1=C(C=CC(=C1)/C(=N/OCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)/C)CN4CC(C4)C(=O)O.C(=C/C(=O)O)\C(=O)O